Transcripts Mesoblast Limited

Equities

Market Closed - Australian S.E. Other stock markets 05:10:05 19/01/2026 GMT			5-day change	1st Jan Change
2.540 ^AUD	-3.79%		-10.88%	-6.62%

07:51am	Mesoblast Limited Provides Feedback Received from the U.S. Food & Drug Administration on Potential Filing of A Biologics License Application for Its Allogeneic Cell Therapy Product Rexlemestrocel-L in Patients with Chronic Low Back Pain	CI
01:30am	Mesoblast Says FDA Acknowledges Potential Efficacy of Cell Therapy Product	MT

29/08/25	Mesoblast Limited, 2025 Earnings Call, Aug 29, 2025
26/02/25	Mesoblast Limited, H1 2025 Earnings Call, Feb 26, 2025
19/12/24	Mesoblast Limited - Special Call
28/08/24	Mesoblast Limited, 2024 Earnings Call, Aug 28, 2024
28/02/24	Mesoblast Limited, Q2 2024 Earnings Call, Feb 28, 2024
28/11/23	Mesoblast Limited - Shareholder/Analyst Call
30/08/23	Mesoblast Limited, Q4 2023 Earnings Call, Aug 31, 2023
04/08/23	Mesoblast Limited - Special Call
25/05/23	Mesoblast Limited, Q3 2023 Earnings Call, May 26, 2023
27/02/23	Mesoblast Limited, Q2 2023 Earnings Call, Feb 27, 2023
23/11/22	Mesoblast Limited - Shareholder/Analyst Call
22/11/22	Mesoblast Limited, Q1 2023 Earnings Call, Nov 23, 2022
30/08/22	Mesoblast Limited, Q4 2022 Earnings Call, Aug 30, 2022
16/06/22	Mesoblast Limited - Special Call
31/05/22	Mesoblast Limited, Q3 2022 Earnings Call, May 31, 2022
24/02/22	Mesoblast Limited, Q2 2022 Earnings Call, Feb 25, 2022
25/01/22	Mesoblast Limited Presents at Edison Open House: Global Healthcare 2022, Jan-25-2022 08:00 AM
28/11/21	Mesoblast Limited - Shareholder/Analyst Call
23/11/21	Mesoblast Limited, Q1 2022 Earnings Call, Nov 23, 2021
31/08/21	Mesoblast Limited, Q4 2021 Earnings Call, Aug 30, 2021
02/06/21	Mesoblast Limited, Q3 2021 Earnings Call, Jun 02, 2021
30/04/21	Mesoblast Limited - Special Call
10/02/21	Mesoblast Limited - Special Call
18/12/20	Mesoblast Limited - Special Call
14/12/20	Mesoblast Limited - Special Call

No results for this search